GlassScriptPhysician profile
Warren L Maresca
NPI 1992726152
$10,076.80
in general payments reported to CMS, 2019-2025
23 companies · $940 in 2025
The $940 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,984 · 2020: $1,365 · 2021: $1,753 · 2022: $1,311 · 2023: $764 · 2024: $960 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,664.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,900.49 | 2019-2025 | Jardiance |
| Pfizer INC. | $951.72 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $740.79 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $731.91 | 2019-2024 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $671.48 | 2019-2022 | |
| Amgen INC. | $447.28 | 2020-2023 | Repatha |
| Merck Sharp & Dohme LLC | $425.49 | 2021-2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $384.45 | 2019-2024 | Lokelma |
| Boston Scientific Corporation | $308.93 | 2019-2020 | |
| Medtronic, INC. | $221.53 | 2022-2025 | Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $161.86 | 2019 | |
| Abbott Laboratories | $144.82 | 2025 | Mitraclip |
| Abiomed | $137.04 | 2023 | Impella |
| Sanofi-Aventis U.S. LLC | $134.27 | 2021-2022 | |
| Esperion Therapeutics, INC. | $133.74 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $133.44 | 2021 | |
| Genzyme Corporation | $125.00 | 2019 | |
| Allergan, INC. | $120.19 | 2019 | |
| Bridgebio Pharma, INC. | $103.53 | 2025 | Attruby |
| Amarin Pharma, INC. | $55.01 | 2021-2023 | |
| Arbor Pharmaceuticals, INC. | $15.46 | 2021 | |
| Cashflow Solutions, LLC | $14.86 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Angiodynamics, INC. | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Maresca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.